For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
|
|
| Basic information |
| Chairman |
President |
Spokesperson |
Telephone |
Address |
ESM Registration Date |
| SHENG-YUNG LIU |
CHOY BOON KEAN |
Eric Lin |
(02)2808-6006 |
15F., NO.27-6, Sec.2, Zhung Zheng E. Rd., Tamsui Dist., New Taipei City.New Taipei, Taiwan |
2010/05/26 |
| Industrycategory |
Key businesses |
| Biotechnology and Medical Care |
Golden Biotechnology Corporation (GBC) was established in September 2002. It is an innovative drug discovery and herbal supplement company dedicated to enhances lives by developing high quality products that prevent and treat diseases. GBC had been approved and categorized as biotech-new drug company and eligible for the incentive program under “Biotech new drug industry development Regulation”. We focus on new drug R&D, IP right, pharmacology, toxicology and clinical studies. Based on our extensive experience with Chinese herbal medicine and our own core chemical database, new chemical entities (NCEs) have emerged during prior drug discovery. Now, we Continuous exploration in biomedical and nutraceutical fields. In addition, enable people to enjoy the benefit of innovative biotechnology. Then, provide the better living and quality of life, to be our ultimately visions. |
| Financial data |
| Cash flows statement
| Item
|
|
|
| Amount(NTD, in thousands) |
| Cash flows from operating activities |
|
|
| Cash flows from investing activities |
|
|
| Cash flows from financing activities |
|
|
Consolidated/Individual
balance sheet
|
Current assets |
|
|
| Non-current assets |
|
|
| Total assets |
|
|
| Current liabilities |
|
|
| Non-current liabilities |
|
|
| Total liabilities |
|
|
| Share capital |
|
|
| Capital surplus |
|
|
| Retained earnings |
|
|
| Other equity interest |
|
|
| Treasury shares |
|
|
| Total equity attributable to owners of parent |
|
|
| Non-controlling interests |
|
|
| Total equity |
|
|
| Book Value per share(NT$) |
|
|
Consolidated/Individual
profit and loss
statement |
Operating revenue |
|
|
| Operating costs |
|
|
| Gross profit from operations |
|
|
| Operating expenses |
|
|
| Net other income (expenses) |
|
|
| Net operating income |
|
|
| Non-operating income and expenses |
|
|
| Profit before tax |
|
|
| Tax expense |
|
|
| Profit from continuing operations |
|
|
| Profit from discontinued operations |
|
|
| Profit |
|
|
| Other comprehensive income |
|
|
| Comprehensive income |
|
|
| Basic earnings per share |
|
|
 Auditor's report on latest financial statements： auditor's report：
|
|
Investors may find more detailed information on the company by visiting the Market Observation Post System.。
|
|
The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.
|
